Adrenal insufficiency - recognition and management
- PMID: 28572228
- PMCID: PMC6297573
- DOI: 10.7861/clinmedicine.17-3-258
Adrenal insufficiency - recognition and management
Abstract
Adrenal insufficiency is characterised by inadequate -glucocorticoid production owing to destruction of the adrenal cortex or lack of adrenocorticotropic hormone stimulation. In primary adrenal insufficiency, lack of mineralocorticoids is also a feature. Patients can present with an insidious onset of symptoms, or acutely in adrenal crisis, which requires prompt recognition and treatment. Chronic glucocorticoid therapy is the most common cause of adrenal insufficiency. The -diagnosis of adrenal insufficiency is made by -demonstrating low basal and/or stimulated serum cortisol and should be -followed by appropriate investigations to establish the -underlying aetiology. Maintenance glucocorticoid -replacement is usually given as a twice or thrice daily hydrocortisone preparation. Patients with primary adrenal insufficiency also require mineralocorticoid. Regular monitoring for features of under- and over- replacement is essential during follow-up. Patient education is a key feature of management of this condition.
Keywords: ACTH; adrenal insufficiency; adrenocorticotropic hormone; glucocorticoid.
© Royal College of Physicians 2017. All rights reserved.
Figures
References
-
- van Staa TP. Leufkens HG. Abenhaim L, et al. Use of oral corticosteroids in the United Kingdom. QJM. 2000;93:105–11. - PubMed
-
- Tomlinson JW. Holden N. Hills RK, et al. Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group. Lancet. 2001;357:425–31. - PubMed
-
- Gibb FW. Stewart A. Walker BR. Strachan MW. Adrenal insufficiency in patients on long-term opioid analgesia. Clin Endocrinol. 2016;85:831–5. - PubMed
-
- Løvås K. Husebye ES. High prevalence and increasing incidence of Addison's disease in western Norway. Clin Endocrinol. 2002;56:787–91. - PubMed
-
- Winqvist O. Karlsson FA. Kämpe O. 21-Hydroxylase, a major autoantigen in idiopathic Addison's disease. Lancet. 1992;339:1559–62. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
